Opioid substitution to improve the effectiveness of chronic noncancer pain control: A chart review

Anesthesia and Analgesia

Volumn 90, Issue 4, 2000, Pages 933-937

  Do Quang Cantagrel, Nathalie ^a   Wallace, Mark S ^a,b   Magnuson, Scott K ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HYDROCODONE; LEVORPHANOL; METHADONE; MORPHINE; OPIATE; OXYCODONE;

ADULT; AGED; BACKACHE; CHRONIC PAIN; DOSE RESPONSE; DROWSINESS; DRUG BIOAVAILABILITY; DRUG DEPENDENCE; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; FIBROMYALGIA; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHY; PRIORITY JOURNAL; PRURITUS; REVIEW; SUSTAINED RELEASE PREPARATION; SYMPATHETIC DYSTROPHY; TREATMENT FAILURE; VOMITING;

EID: 0342313732     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200004000-00029     Document Type: Review

References (25)

1. Stein C. Opioid treatment of chronic nonmalignant pain. Anesth Analg 1997;84:912-4.
2. Cherny NI, Portenoy RK. Cancer pain management. Cancer 1993;72:3393-415.
3. Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases. Pain 1986;25:171-86.
4. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:69-77.
5. Moulin DE, Lezzi A, Amireh R, et al. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143-7.
6. Jadad AR, Carroll D, Glynn CJ, et al. Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia. Lancet 1992;339:1367-71.
7. Bouckoms AJ, Masand P, Murray BG, et al. Chronic nonmalignant pain treated with long-term oral narcotic analgesics. Ann Clin Psychiat 1992;4:185-92.
8. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathl pain: new hypotheses derived from studies of opioid infusion Pain 1990; 43:273-86.
9. Ziegler DK. Opiate and opioid use in patients with refractory headache. Cephalalgia 1994;14:5-10.
10. Markley HG. Chronic headache: appropriate use of opiate analgesics. Neurology 1994;44S:S18-24.
11. Crews JC, Sweeney NJ, Denson DD. Clinical efficacy of methadone in patients refractory to other μ-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer 1993;72:2266-72.
12. Galer BS, Coyle N, Pasternak GW, Portenoy RK. Individual variability in the response to different opioids: report of five cases. Pain 1992;49:87-91.
13. Pick CG, Cheng J, Paul D, Pasternak GW. Genetics influences in opioid analgesic sensitivity in mice. Brain Res 1991;566:295-8.
14. Saeki S, Yaksh TL. Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy. Anesth Analg 1993;77:265-74.
15. Sosnowski M, Yaksh TL. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology 1990;73:1141-7.
16. Dickenson AH. Neurophysiology of opioid poorly responsive pain. Cancer survey 1994;21:5-16.
17. Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 198;25:297-12.
18. Cherny N. Opioid analgesics: comparative features and prescribing guidelines. Drugs 1996;51:713-37.
19. Christrup LL. Morphine metabolites. Acta Anaesthesiol Scand 1997;41:116-22.
20. Labroo RB, Paine MF, Thummel KE, Kharasch ED. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos 1997;25: 1072-80.
21. Savage SR. Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996;11:274-86.
22. Deleted in proof.
23. Kouyanou K, Pither CE, Wessely S. Medication misuse, abuse and dependence in chronic pain patients. I Psychosom Res 1997;43:497-504
24. Portenoy RK. Opioid therapy for chronic nonmalignum paint a review of the critical issues. J Pain Symptom Manage 1996;41: 203-17.
25. Jasinski DR. Tolerance and dependence to ophite; Acta Anaesthesiol Scand 1997;41:184-6.